Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel variant in severe disease of DADA2: involving vasculitic and haematologic features.

Scandinavian journal of rheumatology - 1 Jan 2023

Ayan G, Yagiz B, Cinar O E, Cagdas D, Ozbek D A, Tuncer A, Oguz K K, Ozen S, Alikasifoglu M, Karadag O

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Deaminase
Share to Agammaglobulinemia
Share to Intercellular Signaling Peptides and Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Severe Combined Immunodeficiency

Source

Identifiers

PMID: 35852217
DOI: 10.1080/03009742.2022.2095724

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel variant in severe disease of DADA2: involving vasculitic and haematologic features.PMID 35852217Read ↗

Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.Semantic proximity Read ↗

Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.Semantic proximity Read ↗

DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French cases.Semantic proximity Read ↗

Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2.Semantic proximity Read ↗

Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort.Semantic proximity Read ↗

DADA2 as a Model of Monogenic Immune Vasculopathy: From Immunopathogenesis to Precision Therapeutics.Semantic proximity Read ↗

Early onset is an indication of the severity of DADA2 disease.Semantic proximity Read ↗

A monogenic autoinflammatory disease with fatal vasculitis: deficiency of adenosine deaminase 2Semantic proximity Read ↗

Genotype and Phenotype of Adenosine Deaminase 2 Deficiency: The Experience From Saudi ArabiaSemantic proximity Read ↗

Update on CECR1 molecular diagnostics: new mutations in the deficiency of ADA2 (DADA2) and the North American polyarteritis nodosa (PAN) cohortSemantic proximity Read ↗

A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiencySemantic proximity Read ↗

Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.